APA (7th ed.) Citation

MA, S., CC, W., CD, R., VH, G., CY, W., K, A., . . . M, P. (2026). Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study. Ophthalmology, 133(7), 837. https://doi.org/10.1016/j.ophtha.2026.03.019

Chicago Style (17th ed.) Citation

MA, Singer, Wykoff CC, Riemann CD, Gonzalez VH, Weng CY, Alkhatib K, Amarshi RA, Moody S, and Pao M. "Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study." Ophthalmology 133, no. 7 (2026): 837. https://doi.org/10.1016/j.ophtha.2026.03.019.

MLA (9th ed.) Citation

MA, Singer, et al. "Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study." Ophthalmology, vol. 133, no. 7, 2026, p. 837, https://doi.org/10.1016/j.ophtha.2026.03.019.